Folke Per-Olof Wallström
Fortune : 6 M $ au 31/05/2026
Fortune : 6 M $ au 31/05/2026
Folke Per-Olof Wallström is the founder of Arosia Communication AB. He currently holds the position of Chairman at Camurus AB, Chairman at Arosgruppen Fastigheter Fjärdingen AB, Chairman at Camurus Development AB, and Deputy Director at Reabyran AB. Previously, he served as the Chief Executive Officer of Q-Med AB, President & Chief Executive Officer of Karo Healthcare AB, Chief Executive Officer of Melacure Therapeutics AB, and Chief Executive Officer of Karobio Usa.
He has also held various chairman positions at AROSGRUPPEN Holding AB, Aros Arkitekter AB, Nexttobe AB, Patients Pending Ltd., Aggal Invest AB, Mb Erikssons Bygg & Fastighet AB, Chemilia AB, and Masmastaren Fjardingen AB. Additionally, he served as a Director at Swedish Orphan International Holding AB and Envirotainer AB. He was an Independent Director at Hansa Biopharma AB from 2011 to 2018 and is currently a Director at Q-linea AB. He has also served as a Director at Mediplast AB and NeoDynamics AB, as well as Deputy Director at Addcode Design AB and Patients Pending AB. He has a graduate degree from the University of Uppsala.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAMURUS AB 0,17 % | 31/12/2024 | 102 185 ( 0,17 % ) | 6 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAMURUS AB | Président | 01/01/2015 |
Arosia Communication AB | Fondateur | - |
Camurus Development AB | Président | - |
Reabyran AB | Corporate Officer/Principal | - |
Arosgruppen Fastigheter Fjärdingen AB | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
| Q-LINEA AB | Directeur/Membre du Conseil | 13/06/2023 |
| HANSA BIOPHARMA AB | Directeur/Membre du Conseil | 29/05/2018 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products and drugs | Directeur/Membre du Conseil | 03/06/2010 |
| KARO PHARMA AB (PUBL) | Directeur Général | 23/04/2010 |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 30 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals preparations | Health Technology |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Health Technology |
Karo Healthcare AB
Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products and drugs | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Envirotainer AB
Envirotainer AB Containers/PackagingProcess Industries Manufactures and sells temperature-controlled air cargo containers | Process Industries |
Melacure Therapeutics AB
Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Q-linea AB
Q-linea AB Medical SpecialtiesHealth Technology Develops procedures, instruments, and systems for protein and nucleic acid analysis | Health Technology |
Karobio Usa | |
AROSGRUPPEN Holding AB
AROSGRUPPEN Holding AB Real Estate DevelopmentFinance Provides leasing property and architectural services | Finance |
Mediplast AB
Mediplast AB Medical SpecialtiesHealth Technology Manufactures medical equipment and medical disposable products | Health Technology |
Aros Arkitekter AB
Aros Arkitekter AB Engineering & ConstructionIndustrial Services Provides architectural services | Industrial Services |
NeoDynamics AB
NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Finance |
Patients Pending Ltd.
Patients Pending Ltd. Hospital/Nursing ManagementHealth Services Provides a daily solution to people living with diabetes | Health Services |
Aggal Invest AB
Aggal Invest AB Investment Banks/BrokersFinance Engages in trading securities | Finance |
Arosia Communication AB | |
Arosgruppen Fastigheter Fjärdingen AB | |
Mb Erikssons Bygg & Fastighet AB | |
Reabyran AB | |
Chemilia AB | |
Camurus Development AB | |
Masmastaren Fjardingen AB | |
Addcode Design AB | |
Patients Pending AB |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national